Clinical Trial Update: TMLI/Fludarabine/Melphalan Conditioning for Allogeneic Transplantation in High-risk Myelodysplastic Syndrome or Acute Myeloid Leukemia. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating total marrow irradiation-based conditioning with fludarabine and melphalan for allogeneic transplantation in high-risk myelody…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Fludarabine (Fludarabine)
• Melphalan (Melphalan)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Myelodysplastic Syndromes, Acute Myeloid Leukemia | Phase 2 | Status: NOT_YET_RECRUITING